Skip to main content
Advanced Technical IVT

Juvenile myoclonic epilepsy

Also written as: JME — Juvenile myoclonic epilepsy

A genetic epilepsy syndrome beginning in adolescence, characterized by myoclonic jerks, generalized tonic-clonic seizures, and sometimes absence seizures.

Full Definition

Juvenile myoclonic epilepsy (JME) is a genetic generalized epilepsy syndrome that typically manifests in adolescence (peak age 12-18 years). The hallmark features include myoclonic jerks (especially in the morning), generalized tonic-clonic seizures, and in about one-third of patients, absence seizures. Seizures are often precipitated by sleep deprivation, alcohol consumption, stress, or photosensitivity. The EEG shows generalized polyspike-and-wave discharges. Despite being a lifelong condition, most patients achieve good seizure control with appropriate antiseizure medications, particularly valproate or levetiracetam.

Usage

Usage note: Also known as Janz syndrome after the researcher who first described it comprehensively.

In Context

  • "The teenager's history of morning myoclonic jerks and photosensitivity suggested juvenile myoclonic epilepsy." — Epilepsy clinic assessment
  • "Patients with juvenile myoclonic epilepsy require lifelong treatment and counseling about seizure triggers." — Patient management guidelines

Also known as

JME Janz syndrome

Don't confuse with

juvenile absence epilepsy generalized tonic-clonic seizures alone

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON